Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma

Recruiting now

Conditions studied: Cholangiocarcinoma, Hepatocellular Carcinoma

In brief

The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.

Key facts

Study ID

NCT04340986

Run by

Assistance Publique - Hôpitaux de Paris

People needed

1250

Starts

2020-09-02

Expected to finish

2030-09-01

Last updated by the study team

2024-06-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inclusion Criteria :
• Age ≥ 18 years olds
• Medical care in Nephrology department since 2015
• Cholangiocarcinoma:
• Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease
• Hepatocellular carcinoma:
• Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
• Hepatocellular histologically documented

You may not qualify if…

• Lack of patient non-opposition

Where it is running

• Serviec hépatologie-Hôpital Saint Antoine — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.